{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:49:55Z","timestamp":1655081395017},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["curr drug targets immune endocr metabol disord"],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.2174\/1568008033340270","type":"journal-article","created":{"date-parts":[[2006,3,4]],"date-time":"2006-03-04T11:06:44Z","timestamp":1141470404000},"page":"137-142","source":"Crossref","is-referenced-by-count":4,"title":["The Evolving Therapeutic Approaches for Epstein-Barr Virus Infection in Immunocompetent and Immunocompromised Individuals"],"prefix":"10.2174","volume":"3","author":[{"given":"M.","family":"Okano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Targets - Immune, Endocrine & Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/91798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T05:06:11Z","timestamp":1448255171000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaselect.com\/rpsv\/cgi-bin\/cgi?ini=xref&body=linker&reqdoi=10.2174\/1568008033340270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,6,1]]}},"alternative-id":["1568-0088(20030601)3:2L.137;1-"],"URL":"https:\/\/doi.org\/10.2174\/1568008033340270","relation":{},"ISSN":["1568-0088","0000-0000"],"issn-type":[{"value":"1568-0088","type":"print"},{"value":"0000-0000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}